Abiopharma

The company’s outstanding liabilities as of March 31, 2026, by maturity dates

Clinical trial NCT06455449: enrollment: not set → 240 participants.

Clinical trial NCT07607743: enrollment: not set → 240 participants.

Clinical trial NCT06880744 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-09-01 → 2027-08-01 3. enrollment: not set → 573 participants

Clinical trial NCT07205081 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 72 participants

Clinical trial NCT06136559: enrollment: not set → 1200 participants.

Clinical trial NCT06971809 updates: 1. start date: 2024-10-01 → 2025-05-31 2. completion date: 2025-10-31 → 2026-03-31 3. primary completion date: 2025-10-01 → 2025-12-31 4. enrollment: not set → 60 participants

Clinical trial NCT06901531: enrollment: not set → 500 participants.

Clinical trial NCT07221357: enrollment: not set → 990 participants.

Clinical trial NCT04794530 updates: 1. completion date: 2027-01-31 → 2027-06-01 2. primary completion date: 2026-05-31 → 2026-12-31 3. enrollment: not set → 190 participants